Background/Aims: Psychological complications are prevalent in patients with chronic kidney disease (CKD). This study aimed to investigate mental disorders in stage 4-5 CKD patients, to detect metabolite concentrations in the brain by proton magnetic resonance spectroscopy ( 1 H-MRS) and to compare the effects of different dialysis therapies on mental disorders in end-stage renal disease (ESRD). Methods: The sample population was made up of predialysis (13), hemodialysis (HD) (13), and peritoneal dialysis (PD) patients (12). We collected the baseline data of patients' age, sex, hemoglobin (Hb) and parathyroid hormone（PTH） levels. The predialysis patients served as the control group. The psychological status of the three groups was assessed using three psychological scales.
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Introduction
Chronic kidney disease (CKD) is a highly prevalent disease with an about 10% morbidity rate worldwide [1] . The psychological complications associated with CKD contribute greatly to a poor quality of life, cardiovascular diseases, and increased mortality rate. Previous studies reported associations between poor mental health and cardiac death in dialysis patients [2, 3] . Psychological complications related to CKD are characterized by depression, anxiety, cognitive impairment, fatigue, impaired concentration, memory decline and sleep disturbances. However, these manifestations are usually ignored by clinicians. Depression is one of the most widely acknowledged psychological disorders among CKD patients [4, 5] . About 28% of predialysis patients suffer from major depression and the morbidity is also high in dialysis patients [6] . Another common problem is anxiety, which is inversely proportional to the quality of life [7] . Clinical variables such as age, residual renal function, comorbidities and uremic symptoms are identified to be closely related to anxiety in CKD patients [8] . However, little is understood about the relationship between psychological complications and alterations of metabolites concentrations in specific regions of the brain. Emerging evidence has shown that structural and metabolic alterations in specific brain regions are related to emotional and mental modulation. Increased activation of limbic and paralimbic areas, such as the ACC, hippocampus and amygdala, has been proved to be associated with major depressive disorder [9, 10] . Neurobiological experiment has demonstrated an excessive activity of the ACC in obsessive compulsive disorder (OCD) patients when making conflicting options [11] . The reward/avoidance circuitry of the basal ganglia and the fear circuitry of the amygdala both play a role in the development of social anxiety disorder [12, 13] . The ACC, as a part of cortical regions, is included in the reward/avoidance basal ganglia circuitry [14] . Hippocampus is known to be involved in mnemonic processes. The dorsal hippocampus has spatial navigational functions and the ventral hippocampus is associated with anxiety and context fear learning [15, 16] . Taken together, we chose unilateral ACC, bilateral amygdala, and hippocampus as the major brain regions for this study. Proton magnetic resonance spectroscopy ( 1 H-MRS), a noninvasive and quantitative technique that utilizes magnetic resonance and chemical shift to determine concentrations of chemicals and macromolecules, has been increasingly applied to investigate metabolites in specific regions of the brain in vivo [17, 18] . 1 H-MRS has been used to evaluate metabolites such as N-acetyl Aspartate (NAA), choline-containing compounds (Cho), creatine (Cr), myo-inositol (MI), glutamate and glutamine (Glx) in psychological disorders including depression, anxiety and OCD. Previous studies detected a decreased level of Glx in the anterior brain regions in acute depressed patients [19, 20] , a decreased MI/Cr ratio in the left orbitofrontal region and an increased concentration of Cho in the left and right thalamic nuclei of OCD patients [21, 22] . However, research on the application of 1 H-MRS to assess psychological dysfunctions in CKD patients is limited. Therefore, our study aimed to explore the neuropsychological complications in CKD patients with the method of 1 H-MRS.
Materials and Methods

Subjects
We recruited 13 predialysis patients, 13 HD patients and 12 peritoneal dialysis (PD) patients with ages ranging from 27 to 74 years old, from the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, from July 2015 to September 2016, in this study. Inclusion criteria: (i) 18 to 80 years old inpatients; (ii) Dialysis age over one month or predialysis patients with stage 4-5 CKD; (iii) No cognition-interference factors (color blind, deaf, disabled upper limbs, or poor general condition); (iv) Written informed consent. Exclusion criteria: (i) Diagnosed with intracranial tumor; (ii) Diagnosed with non-atherosclerotic cerebrovascular disease (e.g. vasculitis); (iii) Diagnosed with metabolic encephalopathy such as hepatic encephalopathy and pulmonary encephalopathy; (iv) Diagnosed with epilepsy requiring long-term medication; (v) Alcohol or other drugs addiction; (vi) Cardiac pacemakers, other electrodes or magnetic substances implanted or aneurysm clip in vivo or metal foreign bodies in the eye. The study protocol was approved by the Ethics Committee of Huazhong University of Science and Technology. All participants signed consents after detailed explanation of the study. Age, sex, hemoglobin (Hb, g/L), parathyroid hormone (PTH, pg/ml) were collected as the baseline data.
Psychological assessments
Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS) [23] and Symptom Checklist 90 (SCL 90) were used to assess the psychological status. According to Chinese norm, total score of SDS can be divided into 4 grades: normal (<53 points), mild depression (53-62 points), moderate depression (63-72 points) and severe depression (>72 points). Total score of SAS can be divided into 4 grades: normal (<50 points), mild anxiety (50-59 points), moderate anxiety (60-69 points) and severe anxiety (>70 points). Ten subscales of SCL 90 are F1 Somatizatin, F2 OCD, F3 Interpersonal sensitivity, F4 Depression, F5 Anxiety, F6 Hostility, F7 Phobophobia, F8 Paranoia, F9 Psychopathy, and F10 Others (sleeping and diet). A total score of SCL 90 over 160 points or numbers of positive factors over 43 or any subscale over 2 points is defined as positive. 
MRS methodology
Statistical analysis
All data were analyzed by IBM SPSS statistic 22.0. A two-sided probability value of P< 0.05 was considered as statistically significant. Analysis of variance (ANOVA) followed by Student-Newman-Keuls-q (SNK-q) test was used to analyze the differences between the three groups. Spearman's test was performed for correlation analysis.
Results
High prevalence of psychological disorders in CKD patients
Depression and anxiety were quite common in our CKD patients. The patients mainly suffered from mild to moderate depression or mild anxiety. The prevalence of depression in predialysis, HD and PD patients was 84.62%, 84.62%, and 83.33% (Fig. 1A,  1B, 1C) , while the prevalence of anxiety was 15.38%, 15.38%, and 58.33% (Fig.  1D, 1E, 1F ), respectively.
The total score of SDS (P = 0.58) and SAS (P = 0.15) was not statistically different between the predialysis, HD and PD (Fig. 2) , suggesting a relatively less disordered psychological symptoms such as OCD, interpersonal sensitivity, anxiety, paranoia, and psychopathy in HD patients. SCL 90 results between HD and PD patients were not significantly different, although the mean score was lower in HD patients than in PD patients. In addition, the three groups didn't differ in age, sex, and PTH levels. The mean level of Hb was higher in HD patients than in predialysis and PD patients (P < 0.05, Table1). No correlations between the results of psychological scales and the baseline data （age, sex, Hb and PTH levels）were found (data not shown).
Elevated ratios of Cho/Cr, MI/Cr and Glx/Cr in the ACC were found in HD patients
Differences of Cho/Cr in the ACC mainly existed between predialysis and HD patients (0.98 ± 0.06 vs. 1.14 ± 0.04, P < 0.05), as well as between HD and PD patients (1.14 ± 0.041 vs. 0.98 ± 0.07, P < 0.05) (Fig. 3A) . Differences of MI/Cr in the ACC mainly existed between predialysis and HD patients (0.62 ± 0.02 vs. 0.68 ± 0.02, P < 0.05), as well as between HD and PD patients (0.68 ± 0.02 vs. 0.60 ± 0.02，P < 0.05) (Fig. 3B) . Difference of Glx/Cr in the ACC was found between predialysis and HD patients (2.64 ± 0.10 vs. 2.94 ± 0.09, P < 0.05) (Fig.  3C) . In summary, these results suggested higher ratios of Cho/Cr, MI/Cr and Glx/Cr in the ACC in HD patients than in predialysis and PD patients. (Fig. 4A) . NAA/Cr in the left amygdala was positively correlated with Hb（r = 0.359，P = 0.027） (Fig. 4B) 
C o r r e l a t i o n s between the relative concentrations of metabolites in the brain and the scores of psychological scales
MI/Cr in the left amygdala was negatively correlated with SDS total score (r = -0.370，P = 0.022） (Fig. 5A) . Cho/ Cr in the right amygdala was positively correlated with F2 OCD (r = 0.322, P = 0.048), F5 Anxiety (r = 0.381, P = 0.018) and F9 Psychopathy (r = 0.436, P = 0.006) (Fig. 5B, 5C, 5D ).
Discussion
Psychological disorders with the symptoms of depression and anxiety are quite prevalent in CKD patients. Compared to HD patients, predialysis patients suffered more in OCD, interpersonal sensitivity, anxiety, paranoia, and psychopathy. These are consistent with a previous study showed that predialysis patients had high prevalences of depression and anxiety, which were associated with reduced quality of life [24] . Due to the transition state, the fears, uncertainties, and desperation experienced by predialysis patients may explain why they mostly suffer from the mental disorders. These results strongly suggest the necessity of strengthening human concern and psychological counsel to CKD patients, especially predialysis patients. In our 1 H-MRS studies, we identified relatively higher levels of Cho/Cr, MI/Cr and Glx/Cr in the ACC in HD patients compared to predialysis and PD patients. Cho, as a cell membrane precursor and breakdown product, contributes to neural membrane synthesis and catabolism [25] . Increase of Cho peak in 1 H-MRS is attributed to accelerated turnover of [28, 29] , which helps to maintain a more stable environment for the brain. Increasing evidence indicates that mental disorders, such as depression, are associated with dysfunction of the excitatory neurotransmitters glutamate [19] .
Besides, MI/Cr in the right amygdala was positively correlated with age. Early study reported an increase of MI/Cr in mild cognitive impairment [30] and MI/Cr level was associated with dementia stages [31] . Accordantly, previous studies reported cognitive ability declined on an average rate of 0.04 standardized units per year [32] . Variables such as concentrations of brain metabolites, regional brain volume, and cortical thickness were associated with age-related decline of cognition [33, 34] . Based on these data, we conclude that elevated MI/Cr might be involved in aging-related cognition impairment.
Furthermore, we found a positive correlation between NAA/Cr in the left amygdala and Hb. NAA has been described as a neuronal marker. An increase of NAA in the left amygdala is considered as a functional enhancement and/or an increased density of neuronal cells [35] or improved osmolytic situations in the neuronal environment [36] . Anemia may affect the function of the brain by injuring neuronal cells. Former studies conducted in HD patients showed that anemia resulted in impaired cognition, and correction of renal anemia with erythropoietin improved not only the quality of life but also cognition and depression [37] . The underlying mechanism might be an enhanced delivery of oxygen to subcortical and frontotemporal brain structures, which are associated with mental disorders [38] . Previous studies found a significant decreased NAA concentration in the left amygdala and bilateral orbito-frontal cortex in the children with autism spectrum disorders, and the level of NAA was correlated with the social quotient of these autistic children. Further, oxygenated-Hb, measured by near-infrared spectroscopy machine, was significantly lower in the same areas of the brain. After imitation of emotional facial expression, the oxygenated-Hb level was elevated [39] . In summary, anemia in CKD patients may result in dysfunction or decreased density of neural cells because of decreased oxygen supply to the brain. In addition, the mean level of Hb was higher in HD patients than in predialysis and PD patients, which may be attributed to the normatively use of erythropoietin in HD patients. Next, we found a negative correlation between MI/Cr in the left amygdala and depression. Similarly, a previous study discovered a relatively lower level of MI/Cr in the frontal white matter in acute depression [40] . Another study found elevated levels of MI and MI/Cr in the ACC in fully recovered depressed patients [41] . Lower MI/Cr may reflect dysfunction of glial cells in the left amygdala in CKD patients with mental disorders. Also, alteration of Cho concentrations in the brain may relate to psychological symptoms. Studies reported that Cho in the left thalamus was significantly correlated with social anxiety and its related symptoms [42] . Elevated levels of Cho were found in the ACC of patients with schizophrenia [43] and in the dorsolateral prefrontal cortex of patients with major depressive disorder [44] . Consistent with previous studies, Cho/Cr in the right amygdala was positively correlated with OCD, anxiety and psychopathy in our study, which might suggest a pathophysiological basis of changed Cho/Cr in the right amygdala in mental disorders of CKD patients. It is noteworthy that our study didn't find a significant change of NAA in the amygdala, hippocampus and ACC in CKD patients with psychological disorders. Some studies reported no changes of NAA in depressed patients with antidepressant therapy for several weeks [45, 46] , whereas others found an increase of NAA in the dorsolateral prefrontal cortex of the brain after therapy [47, 48] . Futher studies with a wider range of brain structures and a larger sample size may be needed to obtain a definite answer about the changes of NAA in mental disorders. In addition, we didn't find any association between F4 Depression and changes of metabolites in the brain although depression is quite prevalent in CKD patients. The mean value of F4 Depression was 1.52 ± 0.55 whereas the point of a factor over 2 was considered as positive. The depressed symptom assessed by SCL 90 might be so slight that the changes of the metabolite could not be detected by 1 H-MRS. Our study has several limitations: a relatively small sample size was the major limiting problem, as usually has occurred in previous studies. Another limitation was the lack of an age-matched healthy control. The use of the multiple-voxel method enabled accurate localization but limited findings in restricted regions. Also, to obtain a stable baseline, long Echo time in three-dimensional multi-voxel spectroscopy scanning was used, however, it may be inadequate to analyze the data of MI and Glx. In addition, this study could not provide a causal link between psychological symptoms and changes of metabolites. Finally, all the data were presented as the concentrations of metabolites relative to Cr, which were conventional but limited. It is possible that the absolute concentration of Cr was decreased or increased while the absolute concentrations of other metabolites were unchanged. Future studies may reference the concentrations of metabolites to tissue water to avoid the potential confounding effect of Cr.
Conclusion
The present study reported the psychological status of predialysis and dialysis patients by combining the psychological scales with 1 H-MRS technology to elucidate the pathological changes of metabolites in different regions of the brain. HD therapy showed benefits on patients' mental status. Further studies are required for larger samples clarifying the relationship between the mental status and the changes of metabolites in the brain of CKD patients.
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